CARsgen's First Enrolled Subject in the THANK-u Plus™ Platform-Based Allogeneic CAR-T Trial Achieves sCR at Week 4
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the ...
Le Lézard6h
CARsgen's First Enrolled Subject in the THANK-u Plustm Platform-Based Allogeneic CAR-T Trial Achieves sCR at Week 4
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the ...
News Medical17h
New gene modification enhances CAR-T cell effectiveness against cancer
Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying a specific gene improves the ability of immune cells to combat cancer for ...
emjreviews.com15h
Increased Risk of Skin Cancer After Blood or Marrow Transplant
A study reveals a high risk of skin cancer in BMT survivors, identifying key risk factors and prevention strategies.